quinuclidines has been researched along with ethylcholine aziridinium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iga, Y; Kawanishi, G; Mizobe, F; Nakahara, N; Saito, Y | 1 |
| Brandeis, R; Dachir, S; Fisher, A; Heldman, E; Karton, I; Levy, A; Pittel, Z; Sapir, M | 1 |
| Iga, Y; Kawanishi, G; Mizobe, F; Nakahara, N | 1 |
3 other study(ies) available for quinuclidines and ethylcholine aziridinium
| Article | Year |
|---|---|
Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.
Topics: Animals; Aziridines; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Hippocampus; Learning; Male; Memory; Neuromuscular Blocking Agents; Oxotremorine; Parasympathomimetics; Quinuclidines; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Thiophenes | 1989 |
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.
Topics: Alzheimer Disease; Animals; Aziridines; Behavior, Animal; Choline; Cognition Disorders; Disease Models, Animal; Drug Design; Male; Molecular Structure; Parasympathomimetics; Quinuclidines; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Thiophenes | 1989 |
Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
Topics: Amnesia; Animals; Arecoline; Aziridines; Choline; Male; Memory; Mice; Mice, Inbred Strains; Oxotremorine; Parasympathomimetics; Quinuclidines; Retention, Psychology; Scopolamine; Thiophenes | 1988 |